The BATTLE trial: personalizing therapy for lung cancer.

Cancer Discovery
Edward S KimWaun K Hong

Abstract

The Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial represents the first completed prospective, biopsy-mandated, biomarker-based, adaptively randomized study in 255 pretreated lung cancer patients. Following an initial equal randomization period, chemorefractory non-small cell lung cancer (NSCLC) patients were adaptively randomized to erlotinib, vandetanib, erlotinib plus bexarotene, or sorafenib, based on relevant molecular biomarkers analyzed in fresh core needle biopsy specimens. Overall results include a 46% 8-week disease control rate (primary end point), confirm prespecified hypotheses, and show an impressive benefit from sorafenib among mutant-KRAS patients. BATTLE establishes the feasibility of a new paradigm for a personalized approach to lung cancer clinical trials. The BATTLE study is the first completed prospective, adaptively randomized study in heavily pretreated NSCLC patients that mandated tumor profiling with "real-time" biopsies, taking a substantial step toward realizing personalized lung cancer therapy by integrating real-time molecular laboratory findings in delineating specific patient populations for individualized treatment.

References

May 5, 2005·Journal of the National Cancer Institute·Federico CappuzzoMarileila Varella-Garcia
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jul 15, 2005·The New England Journal of Medicine·Ming-Sound TsaoFrances A Shepherd
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J EdelmanSonia Bisaccia
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Feb 23, 2007·The New England Journal of Medicine·Zhong ZhengGerold Bepler
Jul 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George SimonGerold Bepler
Jan 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Primo N LaraUNKNOWN Southwest Oncology Group
May 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio Vittorio ScagliottiDavid Gandara
Jun 19, 2008·Clinical Trials : Journal of the Society for Clinical Trials·Xian ZhouJ Jack Lee
Sep 26, 2008·The New England Journal of Medicine·Roy S HerbstScott M Lippman
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald B NataleMalcolm Ranson
Aug 12, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alice T ShawA John Iafrate
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Aug 21, 2009·The New England Journal of Medicine·Rafael RosellUNKNOWN Spanish Lung Cancer Group
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig ReynoldsGerold Bepler
Dec 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Yves DouillardEdward S Kim
Feb 5, 2010·Cancer Cell·Alexa B TurkePasi A Jänne
Jun 24, 2010·Clinical Trials : Journal of the Society for Clinical Trials·J Jack Lee Suyu Liu
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward

❮ Previous
Next ❯

Citations

Mar 7, 2013·Cancer Chemotherapy and Pharmacology·Luis R Féliz, Apostolia M Tsimberidou
Jun 7, 2011·Human Genetics·Andrew V Biankin, Thomas J Hudson
Aug 15, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wen ZhangJiangyang Lu
Jan 17, 2014·The Lancet. Respiratory Medicine·Giulia M StellaPaolo M Comoglio
Jun 8, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Zuanel DiazGerald Batist
Jan 11, 2012·Nature Biotechnology·Malorye Allison
Nov 10, 2013·Nature Medicine·Curtis R Chong, Pasi A Jänne
Jul 8, 2011·Nature Reviews. Cancer·Elizabeth A MusgroveRobert L Sutherland
Oct 13, 2011·Nature Reviews. Clinical Oncology·David B Jackson, Anil K Sood
Aug 2, 2012·Nature Reviews. Clinical Oncology·Funda Meric-Bernstam, Gordon B Mills
Mar 1, 2012·Nature Reviews. Clinical Oncology·Eric H Rubin, D Gary Gilliland
Apr 5, 2012·Nature Reviews. Clinical Oncology·Jordi RodónJosep Tabernero
Jun 27, 2013·Nature Reviews. Clinical Oncology·Mark BasikGerald Batist
Feb 6, 2013·Nature Reviews. Clinical Oncology·François-Clément BidardJean Paul Thiery
Nov 14, 2012·Nature Reviews. Gastroenterology & Hepatology·Augusto VillanuevaJosep M Llovet
Feb 6, 2013·Nature Reviews. Rheumatology·Maya H BuchPaul Emery
Jul 10, 2013·Proceedings of the National Academy of Sciences of the United States of America·Shameem FawdarJohn Brognard
Nov 8, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A ThomasG Giaccone
Jan 17, 2012·Journal of the National Cancer Institute·Nathan T IhleGarth Powis
Mar 19, 2013·Journal of the National Cancer Institute·Steven H LinUNKNOWN National Cancer Institute
Jul 17, 2013·Neuro-oncology·Brian M AlexanderDonald A Berry
Oct 17, 2013·Postgraduate Medical Journal·Ramya RamaswamiThomas Newsom-Davis
Mar 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·George PosteJ Milburn Jessup
Jul 4, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·J Jack LeeGuosheng Yin
Oct 24, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lauren Averett ByersJohn V Heymach
Dec 14, 2011·American Journal of Respiratory and Critical Care Medicine·Malcolm M DeCamp, Minesh P Mehta
Apr 17, 2013·BMC Cancer·David J Stewart, Razelle Kurzrock
Sep 6, 2013·Genome Medicine·Angela ChouAndrew V Biankin
Jun 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lorenzo TrippaBrian M Alexander
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tianhong LiDavid R Gandara
Oct 31, 2012·International Journal of Molecular Sciences·Kehua WuWilliam C S Cho
Dec 1, 2012·Archives of Pathology & Laboratory Medicine·Philip T Cagle, Timothy Craig Allen
Jan 11, 2014·Nature Biotechnology·Razelle KurzrockDavid J Stewart

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved